Search is Powered by Google
Medical Devices News

MedSy Launches Device In The UK To Help Stammerers Speak More Fluently

Main Category: Medical Devices
Also Included In: Neurology / Neuroscience;  Ear, Nose and Throat
Article Date: 19 Jul 2007 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
<A HREF="http://www.mlclick.com/mlcl.php?aid=B1F0C1D32D0A9D9782E1C424695C5C0C" target="_blank"><IMG SRC="http://www.mlclick.com/mltr.php?aid=B1F0C1D32D0A9D9782E1C424695C5C0C&b=2" WIDTH="300" HEIGHT="250" BORDER="0" alt="41st World Forum for Medicine, International Trade Fair with Congress"></A>


Current Article Ratings:

Patient / Public:5 stars

5 (2 votes)

Health Professional:not yet rated

Article Opinions: 0 posts

MedSy, a leading European distributor for sub medical products announces the launch of SpeechEasy in the UK. The revolutionary anti stammer device is now available and helps stammerers to speak more fluently.

SpeechEasy(R) is custom made to fit completely within the ear canal and is almost invisible, unlike previous bulkier stammer reducing devices. The coin-sized product works based upon the 'Choral-effect' (also known as the echo effect) which means that the wearer hears his or her own voice with a time delay and a pitch shift. This produces the effect of another person speaking in unison with the stammerer and in most cases will reduce the wearer's stammer significantly. It is very common for individuals with a fairly severe stammer to be able to sing without any hesitation, and this is a similar effect.

Following a successful roll-out in the United States, there are already thousands of users who have benefited from using SpeechEasy(R). According to recent research(*) 80% of SpeechEasy's customers are fluent or almost fluent with the device, with the group indicating that the device has had a very positive impact on their well-being, increased self-confidence and improved interaction resulting in better social and professional relationships. SpeechEasy(R) is supplied via a network of Independent specialist hearing centres here in the UK and is now available at specialist centres in London, Oxford, Ipswich, Manchester, Newcastle, Edinburgh, Lisburn and Lincoln.

Stammering affects around 1% of the UK adult population - about 459,000 people - and approximately 109,000 children between the ages of 5-16 years. Someone who stammers can experience certain limitations in his or her life. These can vary from speech anxiety, avoiding social contact, depression and feelings of inferiority. Stammerers may be offered therapy to try and eliminate it by working with speech and language therapists, or can undertake courses to help themselves. SpeechEasy(R) is an aid to reduce stammering, not a cure, and it should be used as a 'tool' to help reduce the stammer.

(*)Customer satisfaction survey with 489 customers of SpeechEasy (R) by independent agency Rainmaker & Sun Integrated Marketing, April 2004.

To view a short video documentary on SpeechEasy(R), please see here.

http://www.medsy.co.uk




Personalized Homepage Weekly Newsletters Daily News Alerts
Opioid Induced Constipation ADHD Anxiety Asthma Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles All 'How To...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
FDA Approves KAPIDEX (dexlansoprazole) Delayed-Release Capsules For The Treatment Of GERD
03 Feb 2009
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., today announced that the U.S. Food and Drug Administration (FDA) approved KAPIDEX™ (dexlansoprazole)...


Running Tips
Running Tips

Beginning a running program may seem daunting at first, but it is a gradual process. Fitness expert Jonathan Cane provides tips for beginning runners.

more videos are available in our health videos section.